Walk Ahead for a Brain Tumor Cure returns for 10th year
Annual event raises funds for UC Brain Tumor Center
By Elizabeth Clinch
The 10th annual Walk Ahead for a Brain Tumor Cure takes place Sunday, Oct. 20, at Yeatman’s Cove. To register, visit walkahead.org. The 5k run/walk begins at 9 a.m. and the 2K walk begins at 9:15 a.m. Same-day registration opens at 8 a.m.
“Walk Ahead for a Brain Tumor Cure is one of the best days of the year,” said Billi Ewing, brain tumor survivor and Walk Ahead for a Brain Tumor Cure committee member. “I look forward to it the same way I look forward to my own birthday or Christmas day.”
Thousands of walkers and runners will support the research and educational efforts of the University of Cincinnati Brain Tumor Center at the University of Cincinnati Gardner Neuroscience Institute.
“The fact that we have a brain tumor community means there are thousands of people affected by this condition in some way,” Ewing said. “Whether it’s the patient, loved ones, or the caregivers, we are stronger together; the weight of it all is easier to carry when it's shared.”
Far from uncommon, brain tumors affect more 200,000 people in America every year. During the last two decades, the frequency of brain tumors has increased 22 percent overall and 55 percent in people over 65 years of age.
The UC Brain Tumor Center is a regional destination for brain tumor patients, providing innovative and compassionate care while striving to find and cures and discover why these tumors occur.
The funds raised each year through Walk Ahead advance the innovative research necessary to developing new treatments, by annually supporting pilot research grants through UC.
To anyone attending the Walk Ahead for a Brain Tumor Cure for the first time, Ewing advises, “Be prepared for a lot of love. The love and support you will receive from total strangers can be overwhelming.”
Featured image at top: Billi Ewing, center, is a brain tumor survivor and Walk Ahead for a Brain Tumor Cure volunteer.
Tags
Related Stories
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.
College of Medicine alumnae and faculty chair support shared alma mater
May 12, 2026
Michael A. Thomas, MD,[MS1.1] and Cincinnati OB-GYN Megan Kessler, MD, Med ’92 met in the hallways of the University of Cincinnati College of Medicine in the early 1990s.
Western & Southern and UC expand scholarship and co-op support
May 8, 2026
As a longtime employer of University of Cincinnati graduates, Western & Southern Financial Group is now deepening its commitment to empowering the next generation of career-ready professionals. This April, UC faculty and Western & Southern leadership celebrated 10 students as part of the Western & Southern Scholars Program. The scholarship program is a fund launched in 2024 alongside the Western & Southern Accelerated Career Program. The 10 Western & Southern Scholars were selected for their exceptional involvement and impact. These students exemplify the highest standards of academic engagement, having completed meaningful co op experiences and actively contributed to UC’s extracurricular community. Together, these students demonstrate strong leadership, initiative and a commitment to excellence.